L
71
2
VZ
35
-2
NVDA
54
5
ITW
37
-2
ALLE
44
3
GM
85
2
BAX
38
-12
KO
44
-2
KSS
62
3
NKE
28
-12
SHW
43
-10
TMO
60
4
NI
65
-2
ZBH
42
-2
KLAC
72
2
C
82
3
THC
47
2
HAL
50
2
PRU
62
2
SO
46
-5
L
71
2
VZ
35
-2
NVDA
54
5
ITW
37
-2
ALLE
44
3
GM
85
2
BAX
38
-12
KO
44
-2
KSS
62
3
NKE
28
-12
SHW
43
-10
TMO
60
4
NI
65
-2
ZBH
42
-2
KLAC
72
2
C
82
3
THC
47
2
HAL
50
2
PRU
62
2
SO
46
-5
Financhill
Back

First Trust Tactical High Yield ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
42

HYLS
First Trust Tactical High Yield ETF

Last Price:
$41.74
Seasonality Move:
0.16%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$34.75
Seasonality Move:
-0.96%
Sell
42
First Trust Tactical High Yield ETF (HYLS) is a Sell

Is First Trust Tactical High Yield ETF a Buy, Sell or Hold?

  • The current First Trust Tactical High Yield ETF [HYLS] share price is $41.71. The Score for HYLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • HYLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.50. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HYLS Stock Price Chart

What is First Trust Tactical High Yield ETF's stock price today?

  • The First Trust Tactical High Yield ETF share price today is $41.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HYLS is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.

HYLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 47.09 Sell
Chaikin Money Flow: -49243 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.65 - 41.85) Sell
Bollinger Bands (100): (41.73 - 42.09) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.24 Buy
Relative Strength Index (14 RSI): 45.54 Sell
Chaikin Money Flow: 579058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.19 - 34.19) Buy

HYLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.7 Buy
20-day SMA: 41.76 Sell
50-day SMA: 41.81 Sell
200-day SMA: 41.6 Buy
8-day EMA: 41.7 Buy
20-day EMA: 41.74 Sell
50-day EMA: 41.8 Sell
200-day EMA: 41.7 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.82 Sell
20-day SMA: 34.8 Sell
50-day SMA: 33.74 Sell
200-day SMA: 33.57 Sell
8-day EMA: 17.59 Buy
20-day EMA: 8.61 Buy
50-day EMA: 3.75 Buy
200-day EMA: 0.98 Buy

First Trust Tactical High Yield ETF Earnings Growth & HYLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

First Trust Tactical High Yield ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):